ArticleBMC surgery2026
C-Reactive protein and the CALLY index for predicting complicated appendicitis: a retrospective cohort study of 5,428 patients.
Article in BMC surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDistinguishing complicated from uncomplicated appendicitis before surgery remains a critical yet unresolved clinical challenge. Delayed recognition of complicated appendicitis, particularly in cases of perforation or abscess formation, is associated with increased morbidity and mortality. Although various laboratory markers and inflammatory indices have been proposed as markers associated with disease severity, their relative diagnostic performance remains unclear. This study aimed to evaluate and compare the discriminatory performance of conventional laboratory parameters, leukocyte-derived indices, and composite biomarkers for complicated appendicitis.
methodsIn this retrospective single-center cohort study, 5,428 patients who underwent emergency appendectomy between 2015 and 2025 were included. Patients were classified as uncomplicated or complicated appendicitis based on intraoperative findings. Preoperative laboratory parameters, including C-reactive protein, white blood cell count, total bilirubin, leukocyte-derived indices, and composite biomarkers such as the C-reactive protein-albumin-lymphocyte (CALLY) index and the hemoglobin-albumin-lymphocyte-platelet (HALP) index, were analyzed. Receiver operating characteristic analysis was used to assess diagnostic performance, and optimal cut-off values were determined using the Youden index. Multivariate logistic regression was performed to identify variables independently associated with complicated appendicitis.
resultsOf the 5,428 patients, 707 (13.1%) had complicated appendicitis. C-reactive protein demonstrated the highest diagnostic accuracy (AUC: 0.781) and demonstrated the strongest independent association (OR: 5.29). Total bilirubin was also independently associated with complicated appendicitis (OR: 1.21). Leukocyte-derived indices showed limited discriminatory ability, with only the systemic immune-inflammation index remaining significant in multivariate analysis. The CALLY index demonstrated relatively strong discriminatory performance (AUC: 0.747), with lower values associated with increased disease severity.
conclusionsC-reactive protein remains the most robust laboratory marker for identifying complicated appendicitis. Composite biomarkers such as the CALLY index may provide additional value in risk stratification. These findings support the use of routinely available laboratory parameters in clinical risk assessment, although prospective validation is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.